P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder

Autor: Del Valle Rubido, M., Umbricht, D., Shic, F., McCracken, J.T, Scahill, L., Khwaja, O., Squassante, L., Boak, L., Bolognani, F., Fontoura, P., Wall, C., Jou, R., Loomis, R., Lyons, M., Gavaletz, A., Cowen, J., Apelian, T., Jeste, S., Ferretti, C., Taylor, B., Berlin, G., Noone, R., Antar, L., Hollander, E.
Zdroj: In European Neuropsychopharmacology September 2015 25 Supplement 2:S646-S647
Databáze: ScienceDirect